

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | collagen fibril organization (GO:0030199) | 6.45107670 |
| 2 | response to dietary excess (GO:0002021) | 6.15910077 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 5.96909428 |
| 4 | endocardial cushion development (GO:0003197) | 5.57896594 |
| 5 | triglyceride catabolic process (GO:0019433) | 4.90158955 |
| 6 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.87297640 |
| 7 | chondrocyte proliferation (GO:0035988) | 4.79248919 |
| 8 | type B pancreatic cell proliferation (GO:0044342) | 4.73446822 |
| 9 | negative regulation of osteoblast proliferation (GO:0033689) | 4.56479972 |
| 10 | skin morphogenesis (GO:0043589) | 4.55581416 |
| 11 | regulation of sequestering of triglyceride (GO:0010889) | 4.50891733 |
| 12 | endodermal cell differentiation (GO:0035987) | 4.50819386 |
| 13 | regulation of gonadotropin secretion (GO:0032276) | 4.49860182 |
| 14 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 4.45858756 |
| 15 | kidney mesenchyme development (GO:0072074) | 4.45641061 |
| 16 | cell migration involved in sprouting angiogenesis (GO:0002042) | 4.45445609 |
| 17 | cell migration involved in heart development (GO:0060973) | 4.43085570 |
| 18 | acylglycerol catabolic process (GO:0046464) | 4.43031034 |
| 19 | neutral lipid catabolic process (GO:0046461) | 4.43031034 |
| 20 | white fat cell differentiation (GO:0050872) | 4.42192725 |
| 21 | cell adhesion mediated by integrin (GO:0033627) | 4.30354726 |
| 22 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 4.21285069 |
| 23 | cellular response to vitamin (GO:0071295) | 4.13240799 |
| 24 | bone trabecula formation (GO:0060346) | 4.10322718 |
| 25 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 4.00828775 |
| 26 | pericardium development (GO:0060039) | 3.99285187 |
| 27 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.98658374 |
| 28 | hypotonic response (GO:0006971) | 3.97818898 |
| 29 | substrate-dependent cell migration (GO:0006929) | 3.95225822 |
| 30 | brown fat cell differentiation (GO:0050873) | 3.94457147 |
| 31 | ovulation from ovarian follicle (GO:0001542) | 3.85795949 |
| 32 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.83971288 |
| 33 | metanephric mesenchyme development (GO:0072075) | 3.82475857 |
| 34 | positive regulation of fibroblast migration (GO:0010763) | 3.81682365 |
| 35 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.77978313 |
| 36 | lipid particle organization (GO:0034389) | 3.76355037 |
| 37 | endothelial cell morphogenesis (GO:0001886) | 3.75432219 |
| 38 | extracellular regulation of signal transduction (GO:1900115) | 3.74691546 |
| 39 | extracellular negative regulation of signal transduction (GO:1900116) | 3.74691546 |
| 40 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.73377584 |
| 41 | adult feeding behavior (GO:0008343) | 3.67290250 |
| 42 | extracellular matrix assembly (GO:0085029) | 3.67032059 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 3.62527207 |
| 44 | Golgi transport vesicle coating (GO:0048200) | 3.62527207 |
| 45 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 3.61530633 |
| 46 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.58974367 |
| 47 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.57268304 |
| 48 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.55682482 |
| 49 | virion attachment to host cell (GO:0019062) | 3.51572580 |
| 50 | adhesion of symbiont to host cell (GO:0044650) | 3.51572580 |
| 51 | negative regulation of axon guidance (GO:1902668) | 3.47686267 |
| 52 | glycerolipid catabolic process (GO:0046503) | 3.43398240 |
| 53 | negative regulation of embryonic development (GO:0045992) | 3.43024363 |
| 54 | negative regulation of BMP signaling pathway (GO:0030514) | 3.42348807 |
| 55 | extracellular fibril organization (GO:0043206) | 3.41003659 |
| 56 | negative regulation of JUN kinase activity (GO:0043508) | 3.39636156 |
| 57 | positive regulation of protein autophosphorylation (GO:0031954) | 3.39289095 |
| 58 | anterior/posterior axis specification, embryo (GO:0008595) | 3.36469782 |
| 59 | cellular response to leptin stimulus (GO:0044320) | 3.36124364 |
| 60 | valine metabolic process (GO:0006573) | 3.35967783 |
| 61 | neural crest cell development (GO:0014032) | 3.35423504 |
| 62 | response to magnesium ion (GO:0032026) | 3.34332450 |
| 63 | negative regulation of catenin import into nucleus (GO:0035414) | 3.33916125 |
| 64 | estrogen biosynthetic process (GO:0006703) | 3.32370978 |
| 65 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.32334060 |
| 66 | collagen metabolic process (GO:0032963) | 3.32087122 |
| 67 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.32053828 |
| 68 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.31873696 |
| 69 | regulation of osteoblast proliferation (GO:0033688) | 3.31862767 |
| 70 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.31731875 |
| 71 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.25836415 |
| 72 | sprouting angiogenesis (GO:0002040) | 3.21537091 |
| 73 | dermatan sulfate biosynthetic process (GO:0030208) | 3.20122735 |
| 74 | lipid storage (GO:0019915) | 3.19759865 |
| 75 | response to leptin (GO:0044321) | 3.19598606 |
| 76 | blood vessel endothelial cell migration (GO:0043534) | 3.19418294 |
| 77 | negative regulation of stem cell proliferation (GO:2000647) | 3.17017196 |
| 78 | stress fiber assembly (GO:0043149) | 3.16853097 |
| 79 | cellular response to vitamin D (GO:0071305) | 3.16063226 |
| 80 | hyaluronan catabolic process (GO:0030214) | 3.15495101 |
| 81 | cell-substrate junction assembly (GO:0007044) | 3.15404650 |
| 82 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.11996647 |
| 83 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 3.11225985 |
| 84 | peptide hormone processing (GO:0016486) | 3.10481702 |
| 85 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.10412799 |
| 86 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.09992763 |
| 87 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.08865762 |
| 88 | collagen catabolic process (GO:0030574) | 3.06868989 |
| 89 | positive regulation of osteoblast proliferation (GO:0033690) | 3.06608184 |
| 90 | protein localization to endosome (GO:0036010) | 3.06146114 |
| 91 | dermatan sulfate metabolic process (GO:0030205) | 3.05491907 |
| 92 | chondrocyte development (GO:0002063) | 3.04513973 |
| 93 | basement membrane organization (GO:0071711) | 3.03662781 |
| 94 | negative regulation of fatty acid transport (GO:2000192) | 3.02721852 |
| 95 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.01323709 |
| 96 | negative regulation of bone remodeling (GO:0046851) | 3.01238164 |
| 97 | biotin metabolic process (GO:0006768) | 3.00402999 |
| 98 | negative regulation of protein autophosphorylation (GO:0031953) | 2.99683046 |
| 99 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.98208334 |
| 100 | fibril organization (GO:0097435) | 2.97710478 |
| 101 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.97568413 |
| 102 | adhesion of symbiont to host (GO:0044406) | 2.97478293 |
| 103 | smooth muscle tissue development (GO:0048745) | 2.97477026 |
| 104 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.95929741 |
| 105 | positive regulation of vesicle fusion (GO:0031340) | 2.95498936 |
| 106 | regulation of cholesterol storage (GO:0010885) | 2.92837531 |
| 107 | triglyceride biosynthetic process (GO:0019432) | 2.91027610 |
| 108 | positive regulation of endothelial cell migration (GO:0010595) | 2.89315509 |
| 109 | negative regulation of amino acid transport (GO:0051956) | 2.87881688 |
| 110 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.87210164 |
| 111 | lymphangiogenesis (GO:0001946) | 2.86840891 |
| 112 | transcytosis (GO:0045056) | 2.86064583 |
| 113 | multicellular organismal metabolic process (GO:0044236) | 2.85739082 |
| 114 | fatty acid transmembrane transport (GO:1902001) | 2.85469159 |
| 115 | cell-substrate adherens junction assembly (GO:0007045) | 2.85421399 |
| 116 | focal adhesion assembly (GO:0048041) | 2.85421399 |
| 117 | glycine transport (GO:0015816) | 2.84723757 |
| 118 | adherens junction assembly (GO:0034333) | 2.83160779 |
| 119 | membrane raft organization (GO:0031579) | 2.82963782 |
| 120 | neutral lipid biosynthetic process (GO:0046460) | 2.82383303 |
| 121 | acylglycerol biosynthetic process (GO:0046463) | 2.82383303 |
| 122 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.81188343 |
| 123 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.79986717 |
| 124 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.79722906 |
| 125 | actin filament depolymerization (GO:0030042) | 2.78701745 |
| 126 | protein heterotrimerization (GO:0070208) | 2.77912223 |
| 127 | response to vitamin E (GO:0033197) | 2.76439524 |
| 128 | glomerular basement membrane development (GO:0032836) | 2.76135736 |
| 129 | insulin secretion (GO:0030073) | 2.75334567 |
| 130 | muscle cell migration (GO:0014812) | 2.75332904 |
| 131 | positive regulation of axon extension (GO:0045773) | 2.75052948 |
| 132 | multicellular organismal catabolic process (GO:0044243) | 2.74801228 |
| 133 | regulation of axon guidance (GO:1902667) | 2.74468808 |
| 134 | gland morphogenesis (GO:0022612) | 2.74401480 |
| 135 | atrioventricular valve morphogenesis (GO:0003181) | 2.74301771 |
| 136 | endocytic recycling (GO:0032456) | 2.74231450 |
| 137 | glomerular epithelial cell development (GO:0072310) | 2.73754328 |
| 138 | positive regulation of macrophage activation (GO:0043032) | 2.73001468 |
| 139 | wound healing, spreading of cells (GO:0044319) | 2.72815488 |
| 140 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.72288402 |
| 141 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.72272651 |
| 142 | nitric oxide mediated signal transduction (GO:0007263) | 2.69900530 |
| 143 | positive regulation of steroid hormone secretion (GO:2000833) | 2.64936373 |
| 144 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.64918299 |
| 145 | detection of molecule of bacterial origin (GO:0032490) | 2.62539773 |
| 146 | detection of calcium ion (GO:0005513) | 2.61751247 |
| 147 | L-serine transport (GO:0015825) | 2.61711725 |
| 148 | positive regulation of macrophage cytokine production (GO:0060907) | 2.61185184 |
| 149 | cellular response to epinephrine stimulus (GO:0071872) | 2.60142551 |
| 150 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.59864639 |
| 151 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.59648931 |
| 152 | toxin metabolic process (GO:0009404) | 2.59549625 |
| 153 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.58947760 |
| 154 | positive regulation of glomerulus development (GO:0090193) | 2.58523903 |
| 155 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.58503099 |
| 156 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.57572321 |
| 157 | * eating behavior (GO:0042755) | 2.54701208 |
| 158 | positive regulation of calcium ion import (GO:0090280) | 2.53605996 |
| 159 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.53208011 |
| 160 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.50185807 |
| 161 | adrenergic receptor signaling pathway (GO:0071875) | 2.48498739 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.48460918 |
| 163 | growth hormone receptor signaling pathway (GO:0060396) | 2.48042647 |
| 164 | pattern specification involved in kidney development (GO:0061004) | 2.47714067 |
| 165 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.47369160 |
| 166 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.46920720 |
| 167 | regulation of endocrine process (GO:0044060) | 2.45666372 |
| 168 | negative regulation of macrophage differentiation (GO:0045650) | 2.42504375 |
| 169 | cellular response to growth hormone stimulus (GO:0071378) | 2.42239277 |
| 170 | succinate metabolic process (GO:0006105) | 2.42150038 |
| 171 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.41267954 |
| 172 | regulation of steroid hormone secretion (GO:2000831) | 2.40931173 |
| 173 | regulation of female gonad development (GO:2000194) | 2.38146262 |
| 174 | proline transport (GO:0015824) | 2.38141341 |
| 175 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.37838711 |
| 176 | cellular response to lithium ion (GO:0071285) | 2.37805314 |
| 177 | positive regulation of insulin secretion (GO:0032024) | 2.37137398 |
| 178 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.36027415 |
| 179 | alanine transport (GO:0032328) | 2.35086309 |
| 180 | carnitine shuttle (GO:0006853) | 2.34246708 |
| 181 | response to lipoprotein particle (GO:0055094) | 2.33454584 |
| 182 | regulation of amino acid transport (GO:0051955) | 2.33064176 |
| 183 | peptide hormone secretion (GO:0030072) | 2.31762802 |
| 184 | peptide secretion (GO:0002790) | 2.31648281 |
| 185 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.29528019 |
| 186 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.29179466 |
| 187 | glycerol metabolic process (GO:0006071) | 2.28920520 |
| 188 | thioester biosynthetic process (GO:0035384) | 2.28721582 |
| 189 | acyl-CoA biosynthetic process (GO:0071616) | 2.28721582 |
| 190 | iron ion import (GO:0097286) | 2.28679159 |
| 191 | regulation of insulin secretion (GO:0050796) | 2.27683508 |
| 192 | positive regulation of fatty acid oxidation (GO:0046321) | 2.27644268 |
| 193 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.26902247 |
| 194 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.26615223 |
| 195 | oligosaccharide biosynthetic process (GO:0009312) | 2.25749371 |
| 196 | response to epinephrine (GO:0071871) | 2.24999222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82182293 |
| 2 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.92380278 |
| 3 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 3.72067210 |
| 4 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 3.63761100 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.59816300 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22717374 |
| 7 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.56691650 |
| 8 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53225355 |
| 9 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.51161576 |
| 10 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48732585 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.48628410 |
| 12 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.45974267 |
| 13 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.43321723 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.39988495 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.36504393 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.34640409 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31844803 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.26594639 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17944489 |
| 20 | TP53_16413492_ChIP-PET_HCT116_Human | 2.16232505 |
| 21 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14426578 |
| 22 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.08858676 |
| 23 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.08858676 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.07391280 |
| 25 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.04534968 |
| 26 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.99945027 |
| 27 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.97396340 |
| 28 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97245753 |
| 29 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91854639 |
| 30 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90299014 |
| 31 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.87545185 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77638273 |
| 33 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.77625805 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72299099 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.69871006 |
| 36 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.69671809 |
| 37 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.69671809 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69510265 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69215388 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.67628263 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.67285814 |
| 42 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61919866 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61560866 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60650304 |
| 45 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.60447981 |
| 46 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59116368 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58988924 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.58772966 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58307401 |
| 50 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57155933 |
| 51 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57009259 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.54566745 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53779273 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52880519 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.52435727 |
| 56 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51708232 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50671866 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50246988 |
| 59 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.48701423 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48181514 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47266344 |
| 62 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.46848232 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43792755 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42180893 |
| 65 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.41643551 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41532105 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41142927 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40328562 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38837086 |
| 70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37886987 |
| 71 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35075928 |
| 72 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.33006455 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32011878 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31834050 |
| 75 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31613627 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31376922 |
| 77 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.31293697 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29314595 |
| 79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27995028 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27379264 |
| 81 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.26558163 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25764435 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25166994 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23760293 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22914020 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22338992 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21496684 |
| 88 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.20097752 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19498315 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18229900 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17299875 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17143885 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17134592 |
| 94 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16731529 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16141312 |
| 96 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.15698250 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15654601 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15152554 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14947691 |
| 100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.14399100 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13518999 |
| 102 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.13476830 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12335875 |
| 104 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12168267 |
| 105 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.11605883 |
| 106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10979156 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.09920326 |
| 108 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09538621 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07412015 |
| 110 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06677982 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05964427 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05457828 |
| 113 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.05160324 |
| 114 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04211316 |
| 115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04135485 |
| 116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04116478 |
| 117 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03571199 |
| 118 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03486231 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03458270 |
| 120 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03111913 |
| 121 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.02788432 |
| 122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01760856 |
| 123 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.01474306 |
| 124 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01222201 |
| 125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00444382 |
| 126 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00352790 |
| 127 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99977650 |
| 128 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99772755 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 0.99316347 |
| 130 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98648298 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98373102 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98242742 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97257108 |
| 134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97160691 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96253473 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95850202 |
| 137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95843078 |
| 138 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94959236 |
| 139 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.94490411 |
| 140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94367870 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94367870 |
| 142 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93730847 |
| 143 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93730847 |
| 144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93164896 |
| 145 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.92656365 |
| 146 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92401636 |
| 147 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.92057968 |
| 148 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91810129 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91554638 |
| 150 | * PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.91176267 |
| 151 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90938874 |
| 152 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90834793 |
| 153 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90302139 |
| 154 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89734946 |
| 155 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89322658 |
| 156 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89040413 |
| 157 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.88882533 |
| 158 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88378116 |
| 159 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88108387 |
| 160 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87734046 |
| 161 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87462125 |
| 162 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86863233 |
| 163 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86800336 |
| 164 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86081807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 5.82610078 |
| 2 | MP0005670_abnormal_white_adipose | 5.02721313 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.79889551 |
| 4 | MP0003279_aneurysm | 4.37985361 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 4.31512410 |
| 6 | MP0000003_abnormal_adipose_tissue | 4.07493006 |
| 7 | MP0001958_emphysema | 3.83173411 |
| 8 | MP0005379_endocrine/exocrine_gland_phen | 3.74413195 |
| 9 | MP0009384_cardiac_valve_regurgitation | 3.67041813 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.60889688 |
| 11 | MP0002909_abnormal_adrenal_gland | 3.51538885 |
| 12 | MP0002876_abnormal_thyroid_physiology | 3.46225944 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 3.39985183 |
| 14 | MP0005623_abnormal_meninges_morphology | 3.36186363 |
| 15 | MP0005375_adipose_tissue_phenotype | 3.36168312 |
| 16 | MP0004130_abnormal_muscle_cell | 3.34418568 |
| 17 | MP0005257_abnormal_intraocular_pressure | 3.15273352 |
| 18 | MP0003950_abnormal_plasma_membrane | 3.09250297 |
| 19 | MP0005666_abnormal_adipose_tissue | 3.02583119 |
| 20 | MP0006054_spinal_hemorrhage | 3.01012506 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 2.75550857 |
| 22 | MP0001542_abnormal_bone_strength | 2.70421549 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.52466825 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 2.41879126 |
| 25 | * MP0001881_abnormal_mammary_gland | 2.40338461 |
| 26 | MP0002638_abnormal_pupillary_reflex | 2.38192178 |
| 27 | MP0003941_abnormal_skin_development | 2.37808641 |
| 28 | MP0003091_abnormal_cell_migration | 2.24909027 |
| 29 | MP0010368_abnormal_lymphatic_system | 2.24706610 |
| 30 | MP0005023_abnormal_wound_healing | 2.24626009 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 2.12932583 |
| 32 | MP0003959_abnormal_lean_body | 2.10443245 |
| 33 | MP0000767_abnormal_smooth_muscle | 2.03012352 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 2.02741993 |
| 35 | MP0001348_abnormal_lacrimal_gland | 1.96864282 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.82420922 |
| 37 | MP0005508_abnormal_skeleton_morphology | 1.81410865 |
| 38 | MP0002295_abnormal_pulmonary_circulatio | 1.74470757 |
| 39 | MP0000534_abnormal_ureter_morphology | 1.71885091 |
| 40 | MP0003195_calcinosis | 1.71742583 |
| 41 | MP0002254_reproductive_system_inflammat | 1.68417567 |
| 42 | MP0002971_abnormal_brown_adipose | 1.68166983 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.67060772 |
| 44 | MP0003787_abnormal_imprinting | 1.64084779 |
| 45 | MP0005334_abnormal_fat_pad | 1.60363682 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.57593844 |
| 47 | MP0003122_maternal_imprinting | 1.57100149 |
| 48 | MP0001944_abnormal_pancreas_morphology | 1.56335149 |
| 49 | MP0003942_abnormal_urinary_system | 1.55246041 |
| 50 | MP0005535_abnormal_body_temperature | 1.54767319 |
| 51 | MP0010030_abnormal_orbit_morphology | 1.53491392 |
| 52 | MP0005275_abnormal_skin_tensile | 1.50374461 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.49026658 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.48868067 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.48478741 |
| 56 | MP0009115_abnormal_fat_cell | 1.44764454 |
| 57 | MP0001243_abnormal_dermal_layer | 1.43280477 |
| 58 | MP0009053_abnormal_anal_canal | 1.41937700 |
| 59 | MP0003045_fibrosis | 1.34932197 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.32911162 |
| 61 | MP0004272_abnormal_basement_membrane | 1.31538449 |
| 62 | MP0001661_extended_life_span | 1.27741695 |
| 63 | MP0005595_abnormal_vascular_smooth | 1.26903857 |
| 64 | MP0002970_abnormal_white_adipose | 1.25997007 |
| 65 | MP0005448_abnormal_energy_balance | 1.25336610 |
| 66 | MP0000751_myopathy | 1.15459445 |
| 67 | MP0005171_absent_coat_pigmentation | 1.14082201 |
| 68 | MP0003690_abnormal_glial_cell | 1.13939360 |
| 69 | MP0003953_abnormal_hormone_level | 1.12785370 |
| 70 | MP0005452_abnormal_adipose_tissue | 1.11293286 |
| 71 | MP0002693_abnormal_pancreas_physiology | 1.11173608 |
| 72 | MP0002896_abnormal_bone_mineralization | 1.09841864 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 1.03436773 |
| 74 | MP0003385_abnormal_body_wall | 1.03239952 |
| 75 | MP0000733_abnormal_muscle_development | 1.02304453 |
| 76 | MP0002234_abnormal_pharynx_morphology | 1.00780833 |
| 77 | MP0001664_abnormal_digestion | 1.00558670 |
| 78 | MP0005390_skeleton_phenotype | 1.00068698 |
| 79 | MP0003724_increased_susceptibility_to | 0.99265965 |
| 80 | MP0003937_abnormal_limbs/digits/tail_de | 0.96589479 |
| 81 | MP0004043_abnormal_pH_regulation | 0.95893283 |
| 82 | MP0002115_abnormal_skeleton_extremities | 0.95750991 |
| 83 | MP0000428_abnormal_craniofacial_morphol | 0.94528352 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.94462572 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.92731466 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.92237139 |
| 87 | MP0000681_abnormal_thyroid_gland | 0.91538051 |
| 88 | MP0005197_abnormal_uvea_morphology | 0.91327569 |
| 89 | MP0000749_muscle_degeneration | 0.90825990 |
| 90 | MP0004270_analgesia | 0.90655190 |
| 91 | MP0002128_abnormal_blood_circulation | 0.90270615 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.90076970 |
| 93 | MP0002282_abnormal_trachea_morphology | 0.89462496 |
| 94 | MP0004134_abnormal_chest_morphology | 0.88541918 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.87575847 |
| 96 | MP0003448_altered_tumor_morphology | 0.86045937 |
| 97 | MP0004147_increased_porphyrin_level | 0.84867836 |
| 98 | MP0003879_abnormal_hair_cell | 0.84373629 |
| 99 | MP0001756_abnormal_urination | 0.84360311 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.83824960 |
| 101 | MP0001270_distended_abdomen | 0.83605387 |
| 102 | MP0002108_abnormal_muscle_morphology | 0.83331255 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.82940685 |
| 104 | MP0000432_abnormal_head_morphology | 0.81262721 |
| 105 | * MP0002572_abnormal_emotion/affect_behav | 0.80704818 |
| 106 | MP0002168_other_aberrant_phenotype | 0.80285303 |
| 107 | MP0000639_abnormal_adrenal_gland | 0.79242252 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 0.79155581 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.78584179 |
| 110 | MP0002069_abnormal_eating/drinking_beha | 0.78542691 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.78330149 |
| 112 | MP0003755_abnormal_palate_morphology | 0.78017395 |
| 113 | MP0005164_abnormal_response_to | 0.77735183 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 0.77513618 |
| 115 | MP0002734_abnormal_mechanical_nocicepti | 0.77098829 |
| 116 | MP0002060_abnormal_skin_morphology | 0.75987686 |
| 117 | MP0004858_abnormal_nervous_system | 0.75917542 |
| 118 | MP0002113_abnormal_skeleton_development | 0.72735547 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.72666677 |
| 120 | MP0002109_abnormal_limb_morphology | 0.72597839 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.72342645 |
| 122 | MP0004215_abnormal_myocardial_fiber | 0.71983827 |
| 123 | MP0002163_abnormal_gland_morphology | 0.71898498 |
| 124 | MP0003828_pulmonary_edema | 0.71828974 |
| 125 | MP0005193_abnormal_anterior_eye | 0.71622480 |
| 126 | MP0000163_abnormal_cartilage_morphology | 0.70554268 |
| 127 | MP0009745_abnormal_behavioral_response | 0.69590856 |
| 128 | MP0006138_congestive_heart_failure | 0.68784094 |
| 129 | MP0002272_abnormal_nervous_system | 0.68677608 |
| 130 | MP0001970_abnormal_pain_threshold | 0.68449741 |
| 131 | MP0003121_genomic_imprinting | 0.68277501 |
| 132 | MP0003948_abnormal_gas_homeostasis | 0.68169406 |
| 133 | MP0001614_abnormal_blood_vessel | 0.66163406 |
| 134 | MP0001486_abnormal_startle_reflex | 0.65550882 |
| 135 | MP0001502_abnormal_circadian_rhythm | 0.64218659 |
| 136 | MP0000627_abnormal_mammary_gland | 0.64151258 |
| 137 | MP0002102_abnormal_ear_morphology | 0.63657014 |
| 138 | MP0004883_abnormal_blood_vessel | 0.63070409 |
| 139 | MP0000049_abnormal_middle_ear | 0.63009339 |
| 140 | MP0002925_abnormal_cardiovascular_devel | 0.62674257 |
| 141 | MP0004036_abnormal_muscle_relaxation | 0.61971513 |
| 142 | MP0004084_abnormal_cardiac_muscle | 0.61770295 |
| 143 | MP0002184_abnormal_innervation | 0.60775275 |
| 144 | MP0001915_intracranial_hemorrhage | 0.60259902 |
| 145 | MP0005620_abnormal_muscle_contractility | 0.59999547 |
| 146 | MP0002177_abnormal_outer_ear | 0.59623933 |
| 147 | MP0000427_abnormal_hair_cycle | 0.59352843 |
| 148 | MP0001177_atelectasis | 0.59322772 |
| 149 | MP0002063_abnormal_learning/memory/cond | 0.59148316 |
| 150 | MP0005621_abnormal_cell_physiology | 0.58933926 |
| 151 | MP0002116_abnormal_craniofacial_bone | 0.58782800 |
| 152 | MP0003795_abnormal_bone_structure | 0.58461012 |
| 153 | MP0003633_abnormal_nervous_system | 0.57902036 |
| 154 | MP0001175_abnormal_lung_morphology | 0.57222707 |
| 155 | MP0008775_abnormal_heart_ventricle | 0.56938469 |
| 156 | MP0002133_abnormal_respiratory_system | 0.56870067 |
| 157 | MP0005388_respiratory_system_phenotype | 0.56870067 |
| 158 | MP0005165_increased_susceptibility_to | 0.56503503 |
| 159 | MP0008004_abnormal_stomach_pH | 0.56268475 |
| 160 | MP0009046_muscle_twitch | 0.56197724 |
| 161 | MP0002114_abnormal_axial_skeleton | 0.55648389 |
| 162 | MP0003935_abnormal_craniofacial_develop | 0.55385302 |
| 163 | MP0002009_preneoplasia | 0.55224236 |
| 164 | MP0000462_abnormal_digestive_system | 0.53956673 |
| 165 | MP0003566_abnormal_cell_adhesion | 0.52813459 |
| 166 | MP0002064_seizures | 0.52569194 |
| 167 | MP0003115_abnormal_respiratory_system | 0.51979808 |
| 168 | MP0004133_heterotaxia | 0.51522588 |
| 169 | MP0002932_abnormal_joint_morphology | 0.51455974 |
| 170 | MP0003283_abnormal_digestive_organ | 0.50958453 |
| 171 | MP0001299_abnormal_eye_distance/ | 0.50366480 |
| 172 | MP0005646_abnormal_pituitary_gland | 0.48675108 |
| 173 | MP0005187_abnormal_penis_morphology | 0.48473215 |
| 174 | MP0000538_abnormal_urinary_bladder | 0.47857032 |
| 175 | MP0001849_ear_inflammation | 0.46539669 |
| 176 | MP0003252_abnormal_bile_duct | 0.44949073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 8.52291617 |
| 2 | Protrusio acetabuli (HP:0003179) | 6.88790815 |
| 3 | Oligomenorrhea (HP:0000876) | 6.69888418 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.64777214 |
| 5 | Aortic dissection (HP:0002647) | 5.82361666 |
| 6 | Aortic aneurysm (HP:0004942) | 5.53523152 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.45163285 |
| 8 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 5.21313211 |
| 9 | Soft skin (HP:0000977) | 4.71231153 |
| 10 | Hyperglycemia (HP:0003074) | 4.40881127 |
| 11 | Vascular tortuosity (HP:0004948) | 4.39640131 |
| 12 | Menstrual irregularities (HP:0000858) | 4.16667546 |
| 13 | Hypoglycemic seizures (HP:0002173) | 4.10464710 |
| 14 | Ankle contracture (HP:0006466) | 4.03364835 |
| 15 | Acanthosis nigricans (HP:0000956) | 4.02211566 |
| 16 | Atrophic scars (HP:0001075) | 3.92802139 |
| 17 | Abnormality of dentin (HP:0010299) | 3.88736059 |
| 18 | Growth hormone excess (HP:0000845) | 3.88364756 |
| 19 | Symptomatic seizures (HP:0011145) | 3.87736284 |
| 20 | Bladder diverticulum (HP:0000015) | 3.81444564 |
| 21 | Ketoacidosis (HP:0001993) | 3.79450972 |
| 22 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.78516312 |
| 23 | Arterial tortuosity (HP:0005116) | 3.77937497 |
| 24 | Genu recurvatum (HP:0002816) | 3.75048929 |
| 25 | Retinal atrophy (HP:0001105) | 3.67058541 |
| 26 | Neonatal short-limb short stature (HP:0008921) | 3.54955687 |
| 27 | Peritonitis (HP:0002586) | 3.54288264 |
| 28 | Fragile skin (HP:0001030) | 3.46297558 |
| 29 | Large for gestational age (HP:0001520) | 3.45809622 |
| 30 | Broad metatarsal (HP:0001783) | 3.39354217 |
| 31 | Dilatation of the ascending aorta (HP:0005111) | 3.36556994 |
| 32 | Spinal rigidity (HP:0003306) | 3.34326990 |
| 33 | Hyperpituitarism (HP:0010514) | 3.33246479 |
| 34 | Type 1 muscle fiber predominance (HP:0003803) | 3.29431013 |
| 35 | Wormian bones (HP:0002645) | 3.27929153 |
| 36 | Spondylolisthesis (HP:0003302) | 3.19560964 |
| 37 | Bowel diverticulosis (HP:0005222) | 3.17192889 |
| 38 | Insulin resistance (HP:0000855) | 3.17173307 |
| 39 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.14631034 |
| 40 | Follicular hyperkeratosis (HP:0007502) | 3.11931941 |
| 41 | Aortic regurgitation (HP:0001659) | 3.08201951 |
| 42 | Agitation (HP:0000713) | 3.06608993 |
| 43 | Shallow orbits (HP:0000586) | 3.05232650 |
| 44 | Blue sclerae (HP:0000592) | 3.03559269 |
| 45 | Cervical subluxation (HP:0003308) | 3.02148500 |
| 46 | Hyperthyroidism (HP:0000836) | 3.02130776 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.99665599 |
| 48 | Hypertriglyceridemia (HP:0002155) | 2.96788114 |
| 49 | Hyperphosphatemia (HP:0002905) | 2.96141599 |
| 50 | Mitral valve prolapse (HP:0001634) | 2.92096975 |
| 51 | Ulnar bowing (HP:0003031) | 2.91768807 |
| 52 | Unilateral renal agenesis (HP:0000122) | 2.88837527 |
| 53 | Subcapsular cataract (HP:0000523) | 2.84209483 |
| 54 | Absent frontal sinuses (HP:0002688) | 2.78208453 |
| 55 | Abnormal eating behavior (HP:0100738) | 2.76090476 |
| 56 | Hyperparathyroidism (HP:0000843) | 2.75575178 |
| 57 | Wide anterior fontanel (HP:0000260) | 2.75148675 |
| 58 | Mesomelia (HP:0003027) | 2.72732334 |
| 59 | Abnormal delivery (HP:0001787) | 2.69115886 |
| 60 | Biconcave vertebral bodies (HP:0004586) | 2.68430053 |
| 61 | Mitral regurgitation (HP:0001653) | 2.67746685 |
| 62 | Slender build (HP:0001533) | 2.66821904 |
| 63 | Overgrowth (HP:0001548) | 2.66349274 |
| 64 | Gonadotropin excess (HP:0000837) | 2.61727610 |
| 65 | Joint laxity (HP:0001388) | 2.56637782 |
| 66 | Thyroid-stimulating hormone excess (HP:0002925) | 2.54421326 |
| 67 | Elbow flexion contracture (HP:0002987) | 2.52779779 |
| 68 | Hyperextensible skin (HP:0000974) | 2.51882466 |
| 69 | Abnormality of the acetabulum (HP:0003170) | 2.50401306 |
| 70 | Aplasia of the musculature (HP:0100854) | 2.47901362 |
| 71 | Enlarged penis (HP:0000040) | 2.45116475 |
| 72 | Hypercortisolism (HP:0001578) | 2.43604216 |
| 73 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.42430773 |
| 74 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.42430773 |
| 75 | Aortic valve stenosis (HP:0001650) | 2.42222829 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.39601369 |
| 77 | Turricephaly (HP:0000262) | 2.36726275 |
| 78 | Aneurysm (HP:0002617) | 2.36581319 |
| 79 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.36480498 |
| 80 | Vertebral compression fractures (HP:0002953) | 2.35419695 |
| 81 | Mitral stenosis (HP:0001718) | 2.35182868 |
| 82 | Bradycardia (HP:0001662) | 2.32206830 |
| 83 | Decreased circulating renin level (HP:0003351) | 2.31578468 |
| 84 | Accelerated skeletal maturation (HP:0005616) | 2.30343729 |
| 85 | Long foot (HP:0001833) | 2.28683407 |
| 86 | Coronal craniosynostosis (HP:0004440) | 2.28682294 |
| 87 | Nonimmune hydrops fetalis (HP:0001790) | 2.22995942 |
| 88 | Mild short stature (HP:0003502) | 2.21928825 |
| 89 | Hypoplasia of the iris (HP:0007676) | 2.20989232 |
| 90 | Abnormality of carpal bone ossification (HP:0006257) | 2.20709402 |
| 91 | Osteolytic defects of the hand bones (HP:0009699) | 2.19491372 |
| 92 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19491372 |
| 93 | Spinal cord lesions (HP:0100561) | 2.18017341 |
| 94 | Syringomyelia (HP:0003396) | 2.18017341 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16215877 |
| 96 | Pigmentary retinal degeneration (HP:0001146) | 2.15229401 |
| 97 | Complement deficiency (HP:0004431) | 2.13128997 |
| 98 | Camptodactyly of toe (HP:0001836) | 2.10848745 |
| 99 | Failure to thrive in infancy (HP:0001531) | 2.10532528 |
| 100 | Hydroxyprolinuria (HP:0003080) | 2.10255008 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.10255008 |
| 102 | Polyphagia (HP:0002591) | 2.09754908 |
| 103 | Round ear (HP:0100830) | 2.09497780 |
| 104 | Short nail (HP:0001799) | 2.08484620 |
| 105 | Ectopia lentis (HP:0001083) | 2.08306445 |
| 106 | Hypoventilation (HP:0002791) | 2.08258932 |
| 107 | Deviation of the hallux (HP:0010051) | 2.07454265 |
| 108 | Focal motor seizures (HP:0011153) | 2.06621565 |
| 109 | Increased mean platelet volume (HP:0011877) | 2.06114886 |
| 110 | Striae distensae (HP:0001065) | 2.06064228 |
| 111 | Morphological abnormality of the middle ear (HP:0008609) | 2.04516597 |
| 112 | Renal duplication (HP:0000075) | 2.01984471 |
| 113 | Prominent supraorbital ridges (HP:0000336) | 2.01337655 |
| 114 | Epileptiform EEG discharges (HP:0011182) | 2.01306304 |
| 115 | Cerebral aneurysm (HP:0004944) | 2.00381725 |
| 116 | Abnormal ossification of hand bones (HP:0005921) | 1.99761185 |
| 117 | Neoplasm of the heart (HP:0100544) | 1.98885968 |
| 118 | EEG with generalized epileptiform discharges (HP:0011198) | 1.98144125 |
| 119 | Fibular hypoplasia (HP:0003038) | 1.98050455 |
| 120 | Upper limb amyotrophy (HP:0009129) | 1.97546149 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 1.97546149 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97492112 |
| 123 | Abnormality of the vitreous humor (HP:0004327) | 1.96447428 |
| 124 | Hypokalemia (HP:0002900) | 1.95664933 |
| 125 | Bone cyst (HP:0012062) | 1.95423769 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.93948314 |
| 127 | Epidermoid cyst (HP:0200040) | 1.91860071 |
| 128 | Bronchomalacia (HP:0002780) | 1.91068421 |
| 129 | Polar cataract (HP:0010696) | 1.90347678 |
| 130 | Hypsarrhythmia (HP:0002521) | 1.89882170 |
| 131 | Congenital glaucoma (HP:0001087) | 1.89483359 |
| 132 | Disproportionate tall stature (HP:0001519) | 1.89191764 |
| 133 | Adrenal overactivity (HP:0002717) | 1.88102075 |
| 134 | Sparse lateral eyebrow (HP:0005338) | 1.87965139 |
| 135 | Natal tooth (HP:0000695) | 1.87920326 |
| 136 | Knee flexion contracture (HP:0006380) | 1.87507070 |
| 137 | Abnormality of potassium homeostasis (HP:0011042) | 1.87450225 |
| 138 | Bowed forearm bones (HP:0003956) | 1.87285516 |
| 139 | Bowing of the arm (HP:0006488) | 1.87285516 |
| 140 | Difficulty running (HP:0009046) | 1.87257208 |
| 141 | Infantile muscular hypotonia (HP:0008947) | 1.86685316 |
| 142 | Hallux valgus (HP:0001822) | 1.86616161 |
| 143 | Broad long bones (HP:0005622) | 1.85848780 |
| 144 | Macroorchidism (HP:0000053) | 1.85344200 |
| 145 | Skin nodule (HP:0200036) | 1.85330795 |
| 146 | Ketosis (HP:0001946) | 1.85206582 |
| 147 | Pheochromocytoma (HP:0002666) | 1.85135753 |
| 148 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.84346341 |
| 149 | Neonatal hypoglycemia (HP:0001998) | 1.84113535 |
| 150 | Inguinal hernia (HP:0000023) | 1.83969986 |
| 151 | Hip dysplasia (HP:0001385) | 1.83139282 |
| 152 | Late onset (HP:0003584) | 1.82818174 |
| 153 | Osteoarthritis (HP:0002758) | 1.82127023 |
| 154 | Joint stiffness (HP:0001387) | 1.82077090 |
| 155 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.81287408 |
| 156 | Papilledema (HP:0001085) | 1.81077824 |
| 157 | Resting tremor (HP:0002322) | 1.80791261 |
| 158 | Hypoplasia of dental enamel (HP:0006297) | 1.79712487 |
| 159 | Buphthalmos (HP:0000557) | 1.79685318 |
| 160 | Hemiparesis (HP:0001269) | 1.79269549 |
| 161 | Hypothermia (HP:0002045) | 1.78677502 |
| 162 | Wrist flexion contracture (HP:0001239) | 1.77440130 |
| 163 | Onycholysis (HP:0001806) | 1.77324791 |
| 164 | Abnormality of the frontal sinuses (HP:0002687) | 1.76109290 |
| 165 | Mucopolysacchariduria (HP:0008155) | 1.75849428 |
| 166 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75849428 |
| 167 | Rectal prolapse (HP:0002035) | 1.74649958 |
| 168 | Right ventricular cardiomyopathy (HP:0011663) | 1.74592350 |
| 169 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74115206 |
| 170 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74115206 |
| 171 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74115206 |
| 172 | Abnormal platelet volume (HP:0011876) | 1.73989010 |
| 173 | Long toe (HP:0010511) | 1.73683963 |
| 174 | Redundant skin (HP:0001582) | 1.73081472 |
| 175 | Entropion (HP:0000621) | 1.71841141 |
| 176 | Long eyelashes (HP:0000527) | 1.71699540 |
| 177 | Increased number of teeth (HP:0011069) | 1.71396497 |
| 178 | Breech presentation (HP:0001623) | 1.71197283 |
| 179 | Abnormality of the dental pulp (HP:0006479) | 1.70941166 |
| 180 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.70654291 |
| 181 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.70654291 |
| 182 | Single umbilical artery (HP:0001195) | 1.70654291 |
| 183 | Orthostatic hypotension (HP:0001278) | 1.70481341 |
| 184 | Abnormality of skull ossification (HP:0002703) | 1.70246552 |
| 185 | Large hands (HP:0001176) | 1.69507406 |
| 186 | Short clavicles (HP:0000894) | 1.69228635 |
| 187 | Postural tremor (HP:0002174) | 1.68603982 |
| 188 | Hyperkalemia (HP:0002153) | 1.68193394 |
| 189 | Tetraparesis (HP:0002273) | 1.66991793 |
| 190 | Absent eyebrow (HP:0002223) | 1.66637899 |
| 191 | Testicular neoplasm (HP:0010788) | 1.65968541 |
| 192 | Labial hypoplasia (HP:0000066) | 1.65783980 |
| 193 | Neuroendocrine neoplasm (HP:0100634) | 1.64050377 |
| 194 | Aplasia involving bones of the extremities (HP:0009825) | 1.63968483 |
| 195 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.63968483 |
| 196 | Aplasia of the phalanges of the hand (HP:0009802) | 1.63968483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.58874855 |
| 2 | WNK3 | 4.92928072 |
| 3 | PIK3CG | 3.48174982 |
| 4 | SIK1 | 3.39109573 |
| 5 | INSRR | 3.18975559 |
| 6 | TTN | 2.89750466 |
| 7 | PAK2 | 2.87534005 |
| 8 | CAMK1D | 2.87158672 |
| 9 | PTK2 | 2.67497755 |
| 10 | LIMK1 | 2.34746601 |
| 11 | CAMK1G | 2.10628952 |
| 12 | FRK | 2.10129572 |
| 13 | PRKD3 | 2.06868216 |
| 14 | STK38 | 2.04365605 |
| 15 | CASK | 1.90203871 |
| 16 | TESK1 | 1.84552152 |
| 17 | ERBB4 | 1.80379025 |
| 18 | WNK4 | 1.80124374 |
| 19 | FER | 1.76236280 |
| 20 | UHMK1 | 1.73566851 |
| 21 | TRPM7 | 1.68341409 |
| 22 | SIK3 | 1.67224606 |
| 23 | NTRK3 | 1.61986300 |
| 24 | TRIB3 | 1.60938498 |
| 25 | LATS2 | 1.53755661 |
| 26 | EPHA2 | 1.44488035 |
| 27 | DAPK2 | 1.37932111 |
| 28 | MST1R | 1.37269184 |
| 29 | PAK4 | 1.37220925 |
| 30 | EPHB2 | 1.36052217 |
| 31 | TAOK3 | 1.35795120 |
| 32 | MAP3K3 | 1.35052065 |
| 33 | PAK3 | 1.31247231 |
| 34 | LATS1 | 1.29439328 |
| 35 | RIPK1 | 1.20630031 |
| 36 | ROCK1 | 1.19829994 |
| 37 | MAP3K2 | 1.19721669 |
| 38 | DMPK | 1.19113712 |
| 39 | MYLK | 1.15462791 |
| 40 | STK3 | 1.14753486 |
| 41 | MAP2K7 | 1.12589158 |
| 42 | EPHA3 | 1.09512174 |
| 43 | PRKAA2 | 1.08683914 |
| 44 | MELK | 1.07815229 |
| 45 | TIE1 | 1.06063503 |
| 46 | FGFR3 | 1.05827947 |
| 47 | ERN1 | 1.05644553 |
| 48 | FLT3 | 1.04134692 |
| 49 | MAP2K1 | 1.02330580 |
| 50 | PDK4 | 1.02061332 |
| 51 | PDK3 | 1.02061332 |
| 52 | ROCK2 | 0.99144628 |
| 53 | ADRBK1 | 0.98405991 |
| 54 | HIPK2 | 0.97019885 |
| 55 | MAPK13 | 0.96680378 |
| 56 | EPHB1 | 0.96350410 |
| 57 | PIK3CA | 0.95408050 |
| 58 | PRKCH | 0.91502413 |
| 59 | WNK1 | 0.90274452 |
| 60 | PDGFRA | 0.89055990 |
| 61 | FGFR2 | 0.88567492 |
| 62 | BRSK2 | 0.87662937 |
| 63 | BCKDK | 0.87562659 |
| 64 | ILK | 0.87346043 |
| 65 | TAOK2 | 0.87127500 |
| 66 | KIT | 0.86651693 |
| 67 | GRK7 | 0.84196561 |
| 68 | DAPK3 | 0.83862787 |
| 69 | BMPR1B | 0.83318454 |
| 70 | TEC | 0.83118151 |
| 71 | MAP3K1 | 0.81478251 |
| 72 | CAMK1 | 0.79144999 |
| 73 | MOS | 0.77837139 |
| 74 | RPS6KA2 | 0.77383645 |
| 75 | TGFBR2 | 0.76787196 |
| 76 | PLK2 | 0.76738765 |
| 77 | PAK1 | 0.75247754 |
| 78 | ADRBK2 | 0.74300707 |
| 79 | BCR | 0.72927329 |
| 80 | PNCK | 0.72568652 |
| 81 | MAP2K4 | 0.72290764 |
| 82 | MST4 | 0.71999162 |
| 83 | PASK | 0.70592988 |
| 84 | MAP3K4 | 0.70391051 |
| 85 | NTRK2 | 0.69570047 |
| 86 | LMTK2 | 0.69009550 |
| 87 | PDK2 | 0.67651224 |
| 88 | ICK | 0.67001102 |
| 89 | PRKCE | 0.66953037 |
| 90 | PRKD2 | 0.65606013 |
| 91 | MTOR | 0.65590023 |
| 92 | MAP3K12 | 0.64983908 |
| 93 | MAP3K13 | 0.63727072 |
| 94 | RET | 0.63578870 |
| 95 | STK16 | 0.63452240 |
| 96 | AKT3 | 0.61971117 |
| 97 | MAP2K3 | 0.61404177 |
| 98 | CDC42BPA | 0.60982883 |
| 99 | KSR2 | 0.60754226 |
| 100 | MARK2 | 0.60481884 |
| 101 | STK10 | 0.60238806 |
| 102 | SGK223 | 0.59842662 |
| 103 | SGK494 | 0.59842662 |
| 104 | PRKAA1 | 0.59637451 |
| 105 | MAPK7 | 0.59115523 |
| 106 | JAK2 | 0.58238473 |
| 107 | CAMKK2 | 0.57048827 |
| 108 | ABL2 | 0.54786382 |
| 109 | IGF1R | 0.54649099 |
| 110 | PKN2 | 0.53674744 |
| 111 | SIK2 | 0.53574212 |
| 112 | SGK2 | 0.52413826 |
| 113 | PTK2B | 0.51585919 |
| 114 | DAPK1 | 0.51474881 |
| 115 | CDK12 | 0.51078042 |
| 116 | JAK1 | 0.50571198 |
| 117 | MAP3K6 | 0.50525073 |
| 118 | MAPKAPK3 | 0.50165236 |
| 119 | BMX | 0.49405858 |
| 120 | PRKG2 | 0.48827505 |
| 121 | CAMK2G | 0.48204866 |
| 122 | PAK6 | 0.47450845 |
| 123 | ERBB3 | 0.47352605 |
| 124 | NEK1 | 0.46796537 |
| 125 | TNIK | 0.46147427 |
| 126 | CDK5 | 0.45774958 |
| 127 | FGFR4 | 0.44513176 |
| 128 | PIM2 | 0.44206552 |
| 129 | GSK3A | 0.44045667 |
| 130 | NTRK1 | 0.43477061 |
| 131 | PRKACG | 0.41868548 |
| 132 | SGK1 | 0.41589016 |
| 133 | PRKD1 | 0.40242783 |
| 134 | MINK1 | 0.39602476 |
| 135 | STK38L | 0.38592770 |
| 136 | DYRK1B | 0.37278479 |
| 137 | CDK8 | 0.37025025 |
| 138 | DDR2 | 0.36989249 |
| 139 | FGFR1 | 0.36759769 |
| 140 | PDGFRB | 0.35963578 |
| 141 | SGK3 | 0.35583130 |
| 142 | GRK5 | 0.35234979 |
| 143 | NEK9 | 0.35008883 |
| 144 | KSR1 | 0.34714853 |
| 145 | MET | 0.34279918 |
| 146 | ABL1 | 0.33308677 |
| 147 | CDK9 | 0.33235992 |
| 148 | MAPKAPK2 | 0.33222226 |
| 149 | PRKACA | 0.32362038 |
| 150 | NEK6 | 0.32004147 |
| 151 | NEK2 | 0.31410931 |
| 152 | MAP3K14 | 0.31398825 |
| 153 | SMG1 | 0.30540220 |
| 154 | CHEK2 | 0.28647237 |
| 155 | INSR | 0.28438356 |
| 156 | SRC | 0.25475728 |
| 157 | STK24 | 0.23642218 |
| 158 | AURKB | 0.22488904 |
| 159 | CHUK | 0.22046773 |
| 160 | EIF2AK3 | 0.19022857 |
| 161 | RPS6KL1 | 0.18881735 |
| 162 | RPS6KC1 | 0.18881735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.88959608 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.13307933 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.02689206 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.98118861 |
| 5 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.38825975 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.26827146 |
| 7 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.23820913 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.21843750 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.17741471 |
| 10 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 2.14707508 |
| 11 | Adherens junction_Homo sapiens_hsa04520 | 2.14054654 |
| 12 | Amoebiasis_Homo sapiens_hsa05146 | 2.10087662 |
| 13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.07528685 |
| 14 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.99656827 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.98500046 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.94843892 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.82011503 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.81551515 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.79418508 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.70914660 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61966977 |
| 22 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.58689399 |
| 23 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.58471000 |
| 24 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.57823971 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56717248 |
| 26 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.53492033 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47611464 |
| 28 | Bladder cancer_Homo sapiens_hsa05219 | 1.47447814 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.46834910 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46566268 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.45283141 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45013274 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.44046624 |
| 34 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.43663421 |
| 35 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.42093345 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.39840574 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.39042604 |
| 38 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38606558 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34363373 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.33900813 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.33480994 |
| 42 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.32371274 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32238776 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22100619 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21163869 |
| 46 | Pathways in cancer_Homo sapiens_hsa05200 | 1.20667566 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 1.20626456 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.19826392 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 1.19524765 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17803680 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.15988581 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 1.15677892 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15193946 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.13012841 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.12776174 |
| 56 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.09994549 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09287522 |
| 58 | Prostate cancer_Homo sapiens_hsa05215 | 1.09266285 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.08733482 |
| 60 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08473862 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05991717 |
| 62 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03211086 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 1.03179004 |
| 64 | Protein export_Homo sapiens_hsa03060 | 1.02160531 |
| 65 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.00818473 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00660270 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99991955 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.99017210 |
| 69 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98955150 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98397725 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97617005 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95825293 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94621630 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93798029 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91886296 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.91879712 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91742382 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90865407 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89683280 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89561767 |
| 81 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.89400992 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88624881 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88242194 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.87825403 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.87207585 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.86084815 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86080338 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85708855 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84243081 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.82207734 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81158276 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80747144 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80151483 |
| 94 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79385562 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79356898 |
| 96 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77393262 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.76861070 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75735604 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75729492 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75221637 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73889808 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71429631 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.71059986 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69349115 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68585393 |
| 106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68461292 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67728729 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67689563 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67598084 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.67049488 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66160039 |
| 112 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63860701 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62691086 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62669071 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59644282 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59522174 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59177415 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58866863 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58366782 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56763636 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56235374 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55832467 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55657979 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54914657 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54659492 |
| 126 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54505704 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.54251387 |
| 128 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52956766 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52745926 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51094545 |
| 131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49966958 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.49923534 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49331442 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49168897 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.48440051 |
| 136 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47849542 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45865441 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45639543 |
| 139 | Focal adhesion_Homo sapiens_hsa04510 | 0.45194347 |
| 140 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44733449 |
| 141 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43851054 |
| 142 | Gap junction_Homo sapiens_hsa04540 | 0.42293191 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42251024 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41423842 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.41293740 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41094352 |
| 147 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40896865 |
| 148 | Apoptosis_Homo sapiens_hsa04210 | 0.40640472 |
| 149 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39927255 |
| 150 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39827849 |
| 151 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39806168 |
| 152 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38757505 |
| 153 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38662971 |
| 154 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37628538 |
| 155 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37338365 |
| 156 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37176422 |
| 157 | Hepatitis C_Homo sapiens_hsa05160 | 0.36127276 |
| 158 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36089134 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35646272 |
| 160 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35023482 |
| 161 | Axon guidance_Homo sapiens_hsa04360 | 0.34605617 |
| 162 | ABC transporters_Homo sapiens_hsa02010 | 0.33916596 |
| 163 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33574518 |

